NPseal
Commercial- Indications
- Surgical site infections, Closed surgical incisions
Company intelligence / Profile preview
Guard Medical has developed NPseal, an ultraportable, easy-to-use negative pressure wound therapy dressing designed to reduce surgical site complications. The product has received FDA clearance for use on wounds up to 25cm and aims to make proven NPWT technology more accessible by eliminating the need for batteries, tubes, or straps. Clinical utility of NPWT in reducing surgical site complications has been demonstrated in peer-reviewed studies cited by the company.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Guard Medical.